“t-rowe-price” Archives

Entry Author Date Location
Alkermes Nabs $250M It Doesn’t Need, But Could Fend Off Barbarians 01/13/14 Boston
Yub Lands $12,000,000 New Funding 11/19/13 San Francisco
Redfin Raises $50M From Tiger Global, T. Rowe Price, Others 11/14/13 Seattle
MongoDB Secures $150,000,000 New Financing Round 10/04/13 New York
Pure Storage Garners $150,000,000 Series E Round 08/29/13 San Francisco
Eventbrite Secures $60,000,000 New Round 04/22/13 San Francisco
New Relic Garners $80,000,000 New Funding 02/06/13 San Francisco
Ultragenyx, Led by BioMarin Vet, Snags $75M for Ultra-Rare Diseases 12/20/12 San Francisco
Ultragenyx Pharmaceutical Obtains $75,000,000 Series B Round 12/20/12 San Francisco
EverNote Garners $70,000,000 Series D Financing 05/03/12 San Francisco
Castlight Health Receives $100,000,000 Series D Funding Round 05/01/12 San Francisco
oDesk Secures $15,000,000 Series D Funding 03/22/12 San Francisco
Apptio Receives $50,000,000 Series D Financing 03/16/12 Seattle
Apptio Adds $50M to “War Chest,” Plans to Double Sales Bookings 03/15/12 Seattle
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News 06/24/11 Boston
Nuance Buys SVOX, Aveo Sells $100M in Stock, CSN Grabs $165M, & More Boston-Area Deals News 06/22/11 Boston
Tesaro Snags Huge $101M Venture Round to Develop Cancer Drugs 06/21/11 Boston
Gates Foundation Dishes Out Latest $100K Grants for ‘Out of the Box’ Global Health Ideas 04/28/11 Seattle
Investors Pour $200M into Twitter 12/16/10 San Francisco
PacBio Nabs $109M to Make Cheaper, Faster Gene Sequencing Tools 07/14/10 San Francisco
The Show Must Go On: Invest Northwest Forges Ahead Despite Grim Biotech Climate 02/17/09 Seattle
Buy-Side Experts See Major Changes Afoot for Biotech Amid Financial Crisis 10/30/08 National
Page 2 of 2 « previous page